Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering.
Cell Rep. 2021 Jun 1;35(9):109207. doi: 10.1016/j.celrep.2021.109207.
Cell Rep. 2021.
PMID: 34077734
Free PMC article.